Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urology and Nephrology 2022 August;74(4) > Minerva Urology and Nephrology 2022 August;74(4):467-74

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Minerva Urology and Nephrology 2022 August;74(4):467-74

DOI: 10.23736/S2724-6051.21.04145-X

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Green light laser enucleation of the prostate with early apical release is safe and effective: single center experience and revision of the literature

Giovanni FERRARI 1, Salvatore RABITO 1, 2 , Lorenzo GATTI 1, Nicolas N. NTEP 1, Ferdinando D. VITELLI 1, Michele MARCHIONI 3, Bernardo M. ROCCO 2, Salvatore MICALI 2, Riccardo FERRARI 2, Luca CINDOLO 1, 4

1 Department of Urology, Hesperia Hospital, CURE Group, Modena, Italy; 2 Department of Urology, Sant’Agostino Estense Hospital, Modena, Italy; 3 Unit of Urology, Department of Medical, Oral and Biotechnological Sciences, G. D’Annunzio University, Chieti, Chieti-Pescara, Italy; 4 Department of Urology, Villa Stuart Private Hospital, Rome, Italy



BACKGROUND: Green Light laser enucleation of the prostate (GreenLEP) is an endoscopic treatment to treat bladder outlet obstruction in men with large prostate (>100 cc). Herein, we describe our GreenLEP series and describe its safety and efficacy.
METHODS: Between February 2014 and April 2019, 120 patients from a single center underwent en-bloc GreenLEP with early apical release. All procedures were performed with the AMS XPS laser generator (set: 120 W for vaporization and 20 W for coagulation). Morcellation was carried out with the Wolf Piranha morcellator. Data concerning the pre-, intra- and postoperative outcomes were prospectively collected. The follow-up data at 6, 12 months and at the last control were collected.
RESULTS: The median age was 66.0 (IQR: 61.0-71.0) years; 37.5% of the patients were under antiplatelet/anticoagulant therapy, 15.0% had indwelling catheter history. The median prostate volume and the baseline PSA value were 98.5 mL (IQR 83.0-130.0) and 4.2 ng/mL (IQR: 3.2-6.8), respectively. The median operative and lasing time were 65.0 (IQR: 51.0-83.5) and 6.0 (IQR: 6.0-10.0) minutes, respectively. In the postoperative period 1 patient was transfused. The median follow-up was 18.0 (IQR: 12.0-39.5) months. All patients had significant improvement in terms of improvement of uroflowmetry (median from 9 mL/sec [IQR 7.8, 11.0] to 20.0 [IQR 18.0, 22.0], P<0.001) and symptoms control (IPSS median score from 26.0 mL/sec [IQR 22.0, 28.0] to 7.0 [IQR 6.0, 8.0], P<0.001]) over time. After 12 months 1 patient complained of stress incontinence (1 pad/day) and 1 of “de novo” wet urgency.
CONCLUSIONS: En-bloc GreenLEP with early apical release is a safe and effective procedure even for large volume prostates. It allows us to limit the use of laser energy and shorten the operating times with stable and satisfactory long-term outcomes.


KEY WORDS: Lasers; Prostate; Endoscopy

inizio pagina